Monday, September 24, 2018
Close  
  • share this

3 scientists share $500,000 prize for work on cancer therapy

/ 08:44 PM August 15, 2018

This undated photo provided by the National Cancer Institute shows Dr. Steven A. Rosenberg, M.D., Ph.D., winner of the 2018 Albany Medical Center’s Prize in Medicine and Biomedical Research. (Center for Cancer Research, National Cancer Institute via AP)

ALBANY, New York  — Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical prize.

The recipients of the annual Albany Medical Center Prize in Medicine and Biomedical Research, announced Wednesday, are being recognized for their studies of the immune system that have led to innovative treatments for cancer, HIV and other diseases.

ADVERTISEMENT

They are James Allison of the University of Texas MD Anderson Cancer Center; Dr. Carl June of the Perelman School of Medicine, University of Pennsylvania; and Dr. Steven Rosenberg of the National Cancer Institute. They’ll receive the award at a ceremony Sept. 26 in Albany, New York.

“Their research has given hope to many who otherwise faced a certain death sentence, and has inspired the work of hundreds of other researchers to investigate new pathways for treatment,” said Dr. Vincent Verdile, dean of Albany Medical College. “Their impact on the development of cancer immunotherapy – and where it goes from here – is unsurpassed.”

FEATURED STORIES

Immunotherapy harnesses the power of the immune system to attack cancer cells and tumors. In the 1980s, Rosenberg theorized that stimulating white blood cells called T cells could provoke immune reactions. His work led to the first immunotherapy drug approved by the US Food and Drug Administration to treat cancer in 1992.

Former President Jimmy Carter credited the new immune therapy drug Keytruda with shrinking his brain tumors in 2015. The drug, developed using an approach pioneered by Allison, is among a new class of genetically engineered antibody-based medicines that are transforming treatment for several kinds of cancer with drugs that are often less toxic than chemotherapy.

June has led groundbreaking work in developing CAR-T cell therapies, which alter a patient’s own blood cells to turn them into specialized cancer killers. CAR-T therapy became the first FDA-approved personalized cellular therapy for cancer in 2017 with the approval of Kymriah to treat certain pediatric and young adult leukemia patients. /ee

Read Next
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Albany Medical Center Prize in Medicine and Biomedical Research, cancer theraphy, Dr. Carl June, Dr. Steven Rosenberg, James Allison, medical prize
For feedback, complaints, or inquiries, contact us.
newsinfo

Dense swarm of bats causes flap at Vienna airport

September 24, 2018 09:37 PM

newsinfo

At UN, Trump calls for global action on drugs

September 24, 2018 09:19 PM

newsinfo

Italy government adopts anti-migrant decree

September 24, 2018 09:10 PM



© Copyright 1997-2018 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.